G. Charles Robb
2013
In 2013, G. Charles Robb earned a total compensation of $976K as Chief Financial Officer and Secretary at Corcept Therapeutics, a 153% increase compared to previous year.
Compensation breakdown
| Bonus | $128,000 |
|---|---|
| Option Awards | $510,561 |
| Salary | $337,417 |
| Total | $975,978 |
Robb received $510.6K in option awards, accounting for 52% of the total pay in 2013.
Robb also received $128K in bonus and $337.4K in salary.
Rankings
In 2013, G. Charles Robb's compensation ranked 6,722nd out of 12,286 executives tracked by ExecPay. In other words, Robb earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,722 out of 12,286 | 45th |
Division Manufacturing | 2,368 out of 4,612 | 49th |
Major group Chemicals And Allied Products | 710 out of 1,462 | 51st |
Industry group Drugs | 520 out of 1,156 | 55th |
Industry Pharmaceutical Preparations | 414 out of 890 | 54th |
Source: SEC filing on April 22, 2016.
Robb's colleagues
We found four more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2013.